Insmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022

BRIDGEWATER, N.J., Oct. 13, 2022 /PRNewswire/ — Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its third quarter 2022 financial results on Thursday,…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.